What is Indication Extrapolation and Should it be Allowed with Biological Medications? September 23, 2014 By David Charles, M.D. and Mary Ann Chapman, Ph.D. If a prescription medication is approved for the treatment of a…
Ensure Patient Safety When Naming Biological Medications May 23, 2014 By David Charles, MD and Mary Ann Chapman, PhD If requiring biological medications to have unique names would help ensure…
The True Costs of Health Plan Specialty Tiers August 1, 2013 By David Charles, MD and Mary Ann Chapman, PhD An important but rarely asked question is whether it costs more…
